ECLLA News
Welcome to ECLLA News, where we share updates on our work, key activities, and developments across the European CLL community. Stay informed about our initiatives, events, and efforts to strengthen collaboration and improve CLL care across Europe.
ECLLA Newsletter – July 2026 Edition Now Available
The European CLL Association (ECLLA) is pleased to announce the release of the July 2026 edition of the ECLLA Newsletter. In this edition, we share some exciting milestones as ECLLA continues to grow and strengthen its European network. You'll find updates on our...
ECLLA welcomes Assoc. Prof. Yervand Hakobyan as the newest member of the Medical Advisory Committee
Associate Professor Hakobyan is Head of the Department of Hematology and Transfusion Medicine at the National Institute of Health of Armenia, a Board Member of the Armenian Hematology Association, a member of the European Hematology Association (EHA) Community and...
ECLLA Welcomes Its Interim Steering Committee
The European CLL Association (ECLLA) announces the appointment of its Interim Steering Committee, marking an important milestone in the organisation's ongoing development and strategic growth. Bringing together experienced patient advocates and leaders, the Interim...
ECLLA Welcomes New Member from Greece
The European CLL Association (ECLLA) is delighted to welcome the Hellenic Group of Patients with Chronic Lymphocytic Leukaemia (Greece) as the newest member of our growing European network. The Hellenic Group supports and represents people living with CLL in Greece,...
🎉 ECLLA Club Programme 2026 Launch! Join Our First Educational Session “CLL Essentials, Diagnostics & Treatment Pathways” | July, 29th – REGISTRATION OPEN
Dear ECLLA Members, We are delighted to announce the official launch of the ECLLA Club Programme 2026 and to invite you to our first session, CLL Essentials, Diagnostics & Treatment Pathways. This interactive session combines an expert-led presentation with...
🎥 Recordings Now Available: ECLLA Multi-Stakeholder Discussion on Time Off Treatment in CLL
The European CLL Association (ECLLA) is pleased to announce that recording of the multi-stakeholder panel discussion, "Time Off Treatment in CLL – Clinical Control and Patient Priorities in Fixed-Duration Treatment," is now available to watch online. Held on 11 June...
ECLLA Co-Founder Jan Rynne Joins European Discussion on the EU Biotech Act
ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe....
ECLLA Club in Development – First Session Coming Soon
ECLLA Membership Club in Development – First Session Coming Soon ECLLA is pleased to share that preparations are underway for the first session of the ECLLA Club, a new initiative being developed exclusively for ECLLA member organisations. The Membership Club will...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski
European CLL Association - ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the ECLLA...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Dr Brian Koffman
ECLLA is deeply grateful to Dr Brian Koffman, MDCM (retired) MS Ed, Co-Founder and Chief Medical Officer Emeritus, CLL Society Inc., and member of European CLL Association - ECLLA Medical Advisory Board, for bringing both professional expertise and lived experience to...
ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026
The ECLLA team proudly participated in the 31st Congress of the European Hematology Association (EHA 2026), held from June 11–14, 2026, in Stockholm, Sweden. As one of the world's premier hematology events, EHA brings together leading experts, researchers, clinicians,...
📍 Live from Stockholm! Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”
Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Amanda Kracen
ECLLA is proud to work alongside Prof Amanda Kracen, Professor of Psychology and Counselling Psychologist, whose expertise brings an essential perspective to our Medical Advisory Board. At the ECLLA Policy Roundtable in Dublin this May, Prof Kracen highlighted a topic...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Dr Ben Kennedy
ECLLA is incredibly grateful to have Dr Ben Kennedy, Consultant Haematologist at Cork University Hospital, Ireland, as a member of our Medical Advisory Board. At the ECLLA Policy Roundtable in Dublin this May, Dr Kennedy shared valuable insights into one of the most...
🔔 Featured Article: ECLLA Breakfast Panel alongside EHA 2026, Stockholm – REGISTER NOW!
As part of its growing European advocacy activities, ECLLA will host a special breakfast panel discussion alongside EHA 2026 in Stockholm titled: “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the...
ECLLA Newsletter – May 2026 Edition Now Available
The European CLL Association (ECLLA) is pleased to announce the release of the May 2026 edition of the ECLLA Newsletter. This edition highlights some of the key milestones, activities, and developments from ECLLA’s first months of activity, including the growth of the...
World Blood Cancer Day 2026
Today, on World Blood Cancer Day, we support patients, families, healthcare professionals (HCPs), and patient advocacy groups (PAGs), and we advocate for better outcomes for everyone affected by blood cancers across Europe and beyond. ❤️ 🩸 Chronic lymphocytic leukemia...
ECLLA Joins the EHA Patient Advocacy Committee
ECLLA is proud to announce that it has joined the European Hematology Association (EHA) Patient Advocacy Committee (PAC) ahead of the EHA 2026 Congress. The EHA PAC plays an important role in ensuring that patient voices are represented within EHA activities,...
ECLLA Medical Advisory Board
ECLLA is proud to announce the formation of its Medical Advisory Board, bringing together internationally recognised experts from the fields of hematology, oncology, psychology, and patient-centred care. The establishment of the Board represents an important milestone...
Thank you to everyone who contributed to the first ECLLA European Policy Roundtable
Thank you to everyone who contributed to the first ECLLA European Policy Roundtable 2026 – “Pathways to Equitable CLL Care Across Europe.” We are grateful to ECLLA members and patient leaders, clinicians, policy experts and partners who came together in Dublin with a...